February 23, 2017 3:54 PM ET

Biotechnology

Company Overview of DermTech, Inc.

Company Overview

DermTech International, a molecular diagnostic company, is engaged in developing and marketing gene expression tests to facilitate the diagnosis of dermatologic conditions. The company offers Adhesive Skin Sample Collection Kit, which consists of adhesive patches, instructions for use, a marking pen for lesion outlining, and a pre-addressed and prepaid return shipping pack. Its Adhesive Skin Sample Collection Kit allows for the collection of skin samples with minimal patient discomfort. The company also provides Pigmented Lesion Assay for reducing unnecessary surgical biopsy procedures and enhancing diagnostic accuracy; ribonucleic acid extraction services; and a smart phone based photoinfor...

11099 North Torrey Pines Road

Suite 100

La Jolla, CA 92037

United States

Founded in 1995

20 Employees

Phone:

858-450-4222

Fax:

858-200-3877

Key Executives for DermTech, Inc.

Chief Executive Officer, President and Director
Age: 50
Chief Financial Officer, Principal Financial & Accounting Officer, Secretary and Treasurer
Age: 60
Chief Operating Officer
Age: 52
Chief Medical Officer
Director of Business Administration
Compensation as of Fiscal Year 2016.

DermTech, Inc. Key Developments

DermTech, Inc. Announces Validation Study Publication

DermTech, Inc. announced the publication of the "Development and Validation of a Non-Invasive 2-Gene Molecular Assay for Cutaneous Melanoma", in theJournal of the American Academy of Dermatology(Ms.No. JAAD-D-16-00647R1). This validation study sought to provide clinicians with a differentiated and accurate noninvasive diagnostic modality. A 2-gene classification method based on LINC00518 and preferentially expressed antigen in melanoma gene expression (PRAME) was evaluated and validated in 555 pigmented lesions (157 training and 398 validation samples) obtained noninvasively via adhesive patch biopsy. Results were compared with standard histopathologic assessment in lesions with a consensus diagnosis among 3 experienced dermatopathologists. In 398 validation samples, LINC00518 and/or PRAME detection appropriately differentiated melanoma from non-melanoma samples with a sensitivity of 91% and a specificity of 69%. LINC00518 and PRAME were established in both melanoma samples obtained via non-invasive adhesive patch biopsy and underlying FFPE samples of surgically excised primary melanomas and in melanoma lymph node metastases. This newly published validation study demonstrates how non-invasive pigmented lesion assay classifies clinically difficult to differentiate pigmented lesions into melanoma and non-melanoma groups. It offers dermatologists a tool to help with diagnostic challenges that may be inherently linked to the visual image and pattern recognition approach.

DermTech, Inc. Names Mr. Matthew Posard to the Board of Directors

DermTech, Inc. announced it has added Mr. Matthew Posard to its board of directors. Additionally, the company announced the continued expansion of its commercial team with regional sales personnel. Mr. Posard held influential leadership roles with companies including Illumina, Trovagene, Biosite/Alere and Gen-Probe.

DermTech, Inc. Announces Sales and Marketing Collaboration with Dermpath Diagnostics

DermTech, Inc. announced a sales and marketing collaboration with Dermpath Diagnostics. Dermpath Diagnostics is a business of Quest Diagnostics Incorporated. Under the arrangement, Dermpath Diagnostics will provide specialty dermatology representatives in up to 10 regional territories across the United States to assist DermTech in marketing its Pigmented Lesion Assay (PLA) for assessing melanocytic lesions (nevi and melanoma) via gene expression.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 7, 2016
--
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DermTech, Inc., please visit www.dermtech.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.